Product Information
HYDROXYZINE HCL 10 MG TABLET is a generic product labeled by PuraCap Laboratories LLC, priced at $0.0287 per EA under NDC 24658078105. Its NADAC has been published 32 times since Feb 25, 2026.
Strength
10 mg/1
Manufacturer
PuraCap Laboratories LLCNDC
24658078105
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROXYZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040600On Market Since
7/21/2021
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE HCL 10 MG TABLET has been published 32 times since Feb 25, 2026, and over the history we have for it it has declined 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0287 per EA |
|---|---|
| All-time high | $0.0315 (Mar 11, 2026) |
| All-time low | $0.0286 (Aug 19, 2026) |
| 52-week high | $0.0315 |
| 52-week low | $0.0286 |
| Median price | $0.0307 |
| Average price | $0.0302 |
| Largest weekly change | -4.9% (Jul 22, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PuraCap Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydroxyzine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROXYZINE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE HCL 10 MG TABLET, manufactured by PuraCap Laboratories LLC, is $0.0287 per EA (NDC 24658078105), effective Sep 30, 2026.
How has the price of HYDROXYZINE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE HCL 10 MG TABLET has declined 8.9%. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE HCL 10 MG TABLET?
Since Feb 25, 2026, the NADAC for HYDROXYZINE HCL 10 MG TABLET has ranged from a low of $0.0286 (Aug 19, 2026) to a high of $0.0315 (Mar 11, 2026), with a median of $0.0307 per EA.
Are there cheaper alternatives to HYDROXYZINE HCL 10 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROXYZINE HCL 10 MG TABLET, is $0.0286 per EA — about 0% below HYDROXYZINE HCL 10 MG TABLET.
Who manufactures HYDROXYZINE HCL 10 MG TABLET?
HYDROXYZINE HCL 10 MG TABLET (NDC 24658078105) is labeled by PuraCap Laboratories LLC, and CMS classifies it as a generic product.